Aster DM Healthcare Ltd had raised $45.68 million (Rs 294.04 crore) from anchor investors including Canada’s second largest pension fund Caisse de dépôt et placement du Québec (CDPQ) and the UK-based First State Investments ahead of its initial public offering (IPO).
The company allotted 154,75,843 equity shares at the price band of Rs 180-190 per share to eight anchor investors, it disclosed in a BSE filing on February 9.
Other anchor investors included Hong Kong’s Karst Peak Asia Master Fund, Deutsche Bank’s Asia investment arm DB International Asia, Societe Generale, SBI Magnum, SBI Pharma Fund, and Sundaram Mutual Fund.
While First State Investments bought a little over 2.5 million shares, CDPQ purchased in excess of 1.1 million and Karst Peak bought about 2.3 million equity shares, the filing said.
CDPQ, which set up its India office in March 2016, has made investments worth over $3 billion in India so far, MINT reported. Its existing investments in the country include TVS Logistics, and Edelweiss reconstruction company.
Aster DM IPO comprises a fresh issue of shares of Rs725 crore and an offer for sale of 13.42 million shares by promoter Union Investments Pvt. Ltd. At the upper end of the price band, the share sale will fetch promoters about Rs255 crore.The proceeds from the fresh issue will be utilized to repay debt, and purchase medical equipment.
The company’s IPO opened on February 12 and the first day of share sale witnessed an overall subscription of 26%. The offer will close on 15 February. Merchant bankers including Kotak Mahindra Capital, Axis Capital, Goldman Sachs, ICICI Securities, JM Financial and Yes Securities, are managing the company’s IPO.
Founded by Dr. Azad Moopen in 1987 as a single clinic, Aster DM is a healthcare network with over 316 operating facilities across 9 countries, including 19 hospitals, 95 clinics and 202 retail pharmacies across India, Middle East and Far East, according to its website. Headquartered in Dubai, the company’s network now encompasses 19,593 employees, 2296 doctors with several JCI accredited hospitals, clinics and diagnostic centres.
In India, it operates hospitals in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru and Hyderabad under the Aster Medcity, Malabar Institute of Medical Sciences (MIMS) and Aster Prime Hospital brands. Its clinics in India are located in Kozhikode and Bengaluru.
Aster DM has joined other pharmaceutical and healthcare companies that have gone public over the past 2-3 years. These include ChrysCapital-backed Eris Lifesciences, Dr Lal PathLabs Ltd, Thyrocare Technologies Ltd, Narayana Hrudayalaya Ltd, and HealthCare Global Enterprises Ltd, among others.